SAN DIEGO (AP) _ Cytori Therapeutics Inc. (CYTX) on Thursday reported a loss of $4.8 million in its third quarter.
On a per-share basis, the San Diego-based company said it had a loss of 14 cents.
The developer of cell therapies posted revenue of $1.8 million in the period.
In the final minutes of trading on Thursday, the company's shares hit 40 cents. A year ago, they were trading at $1.72.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTX at https://www.zacks.com/ap/CYTX
Find out what activities and attractions make these 20 cities and town some of the best places to retire around the world
Generics are a great way to save money in lots of cases, but here is a look at some clear exceptions